Reshaping Evolution
3 CRISPR editing innovations to watch in 2022
Researchers See a New Path to Curbing Methane in Rice
First sickle cell patient treated with CRISPR gene-editing still thriving
These gene-editing startups are aiming to solve one of CRISPR’s biggest problems. Here’s how they could upend biotech in 2022.
C&EN’s 2021 10 Start-Ups to Watch
How To Maximize Non-Emergency Medical Transportation’s Potential To Address Social Determinants Of Health
Andreessen Horowitz Leads $22M in Funding for Thyme Care to Improve Patient Outcomes, Close Gaps in Health Disparities, and Drive Value-Based Cancer Care
CRISPR: A guide to the health revolution that will define the 21st century
A startup delivers mental health care to those missed by the unicorns
Genetic Dreams, Genetic Nightmares
Newly-Discovered ‘Borg’ DNA Is Unlike Anything Scientists Have Ever Seen
Crispr gene-editing ‘revolution’ treats internal organ for first time
He Inherited A Devastating Disease. A CRISPR Gene-Editing Breakthrough Stopped It
CRISPR injected into the blood treats a genetic disease for first time
New Technology Could Unlock The Secrets Of Every Protein In The Body
Nautilus Biotechnology Debuts as Publicly Traded Company, Seeks to Deliver on the Untapped Potential of the Human Proteome
Concert Health Inks Two More Collaborative Care Partnerships, Continues Aggressive Growth
Recursion CSO heads west for mini-brain upstart
A View From The Top: Six Healthcare Execs On How To Close The Nation’s Mental Health Care Gap
NFT for Nobel Prize-Winning Data to Be Auctioned by UC Berkeley
Renowned ‘Drug Hunter’ Joins Team To Cure Challenging Brain Diseases
You Can Buy a Piece of a Nobel Prize-Winning Discovery
Herophilus Appoints Sharath Hegde, Ph.D. as Chief Scientific Officer as it Scales Drug Discovery Effort for Complex Brain Diseases
Star Trek-style scanner creates ‘digital twin’ to track your health
Tory Burch and Nobel Prize winner Jennifer Doudna are teaming up to help women scientists
Doudna and Arnold Chat “Nobel to Nobel”
Meet Dr. Jennifer Doudna: She’s Leading the Biotech Revolution
Q Bio unveils ‘digital twin’ whole-body imaging platform, with Kaiser Permanente backing
Bloomberg Studio 1.0: CRISPR Co-Inventor Dr. Jennifer Doudna
The 20(+1) under 40: Inside the next generation of biotech leaders
Scribe Therapeutics snags $100M for engineered CRISPR tech, pipeline
Doudna’s Scribe Rewrites CRISPR Drug Development with $100 Million Series B
Scribe, Jennifer Doudna’s newest startup, nabs a mega-round and a vocal investor
A New Approach To Crispr – Scribe Therapeutics Designs Novel Crispr Molecules
Jennifer Doudna on the Pandemic Year: The Power of Mission-Driven Science
“The Code Breaker”: Jennifer Doudna and how CRISPR may revolutionize mankind
After the Nobel, what next for Crispr gene-editing therapies?
What Gene Editing Can Do for Humankind
The Code Breaker and Crispr People — the ethics of editing humanity
Nobel laureates Frances Arnold and Jennifer Doudna on prizes, pandemics, and Jimmy Page
Concert Health Completes $14M Series A Financing to Deliver Evidence-based Behavioral Health Services at Scale
Why Jennifer Doudna’s DNA discovery is revolutionising the way we tackle disease
The virus-free scientific breakthroughs of 2020, chosen by scientists
How Science Beat the Virus
As Next Insurance makes its first acquisition, insurtech looks energetic
On GPS: Re-writing the code of life
Will Nobel winner Jennifer Doudna’s Crispr gene-editing tool lead to designer babies?
CommonSpirit Health Expands Behavioral Health Support through Primary Care Collaboration in Partnership with Concert Health
The Nobel Prize in Chemistry 2020
Scribe Therapeutics launches a platform for engineering CRISPR-based therapeutics
The latest Jennifer Doudna startup launches with a Biogen partnership and eyes on big targets few CRISPR companies have chased
Some Covid-19 Patients Show Signs of Heart Damage Months Later
Jennifer Doudna sees CRISPR gene-editing tech as a Swiss Army knife for COVID-19 and beyond
How CRISPR is helping scientists create a better coronavirus test
If You’ve Just Had Covid, Exercise Might Not Be Good for You
‘Carnage’ in a lab dish shows how the coronavirus may damage the heart
Expert panel lays out guidelines for germline editing, while warning against pursuit of ‘CRISPR babies’
Still too soon to try altering human embryo DNA, panel says
Viruses, lords of creation – exploring the little-known viral universe
